• Zealand Pharma issued 31,247 new shares from employee warrant exercises, lifting share capital by DKK 31,247.
• Proceeds totaled DKK 4.58 million; warrants were exercised at DKK 90.7 for 17,528 shares and DKK 218 for 13,719.
• Registered share capital will be DKK 71.61 million, representing 71,610,005 shares, once the increase is filed with authorities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zealand Pharma A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609101100PRIMZONEFULLFEED1001262070) on September 10, 2026, and is solely responsible for the information contained therein.